High mRNA expression of PSMA1 and PSMA2 was significantly associated with PPS for lung cancer patients, with HR = 0.77 (0.60–0.99), p = 0.043 and HR = 0.65 (0.51–0.84), p < 0.001, respectively. This evidence concerns the gene PSMA2 and lung carcinoma.